Sources of heterogeneity in case–control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia

Review: ACE inhibitors reduce risk for pneumonia

(2013) Randolph J. Lipchik   ANNALS OF INTERNAL MEDICINE

Statin Use and Fracture Risk

(2013) Lawrence C. McCandless   EPIDEMIOLOGY

Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Associated with Acute Respiratory Distress Syndrome among Caucasians

(2013) Z Hu et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

The role of vitamin D supplementation in the risk of developing pneumonia: three independent case–control studies

(2013) Hilde H F Remmelts et al.   THORAX

Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins

(2012) Goodarz Danaei et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Angiotensin-converting enzyme inhibitor use and pneumonia risk in community-dwelling older adults: results from a population-based case-control study

(2012) Sascha Dublin et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis

(2012) D. Caldeira et al.   BMJ-British Medical Journal

Microbial evaluation of proton-pump inhibitors and the risk of pneumonia

(2011) S. C. A. Meijvis et al.   EUROPEAN RESPIRATORY JOURNAL

Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial

(2011) Sabine CA Meijvis et al.   LANCET

PMC31 THE MONDRIAAN PROJECT: THE DUTCH HEALTH CARE LANDSCAPE AS A POPULATION LABORATORY

(2011) OH Klungel et al.   VALUE IN HEALTH

Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis

(2010) C.-S. Eom et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Negative Controls

(2010) Marc Lipsitch et al.   EPIDEMIOLOGY

Inhaled drugs as risk factors for community-acquired pneumonia

(2010) J. Almirall et al.   EUROPEAN RESPIRATORY JOURNAL

Time trends in primary-care morbidity, hospitalization and mortality due to pneumonia

(2009) A. B. VAN GAGELDONK-LAFEBER et al.   EPIDEMIOLOGY AND INFECTION

Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study

(2009) Puja R. Myles et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials

(2008) Liam Smeeth et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Use of ACE inhibitors and risk of community-acquired pneumonia: a review

(2008) Petros I. Rafailidis et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Population-based study of the effectiveness of bone-specific drugs in reducing the risk of osteoporotic fracture

(2008) Sylvie Perreault et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Risk and Outcome of Pneumonia

(2007) Ewoudt M.W. van de Garde et al.   CHEST